News

Press Releases

10/17/17
BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in Japan
10/06/17
Published Study of Licensed Technology to Treat Lumbar Degenerative Disc Disease
06/14/17
BioRestorative Therapies to Present at 6th Annual Marcum MicroCap Conference
04/20/17
BioRestorative Therapies Receives Notice of Acceptance for Key Metabolic Patent in Australia
02/08/17
BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease
BioRestorative Therapies: A Stem Cell Biotechnology Company